
Via Scientific
The Integrated Bioinformatics Operating System.
Date | Investors | Amount | Round |
---|---|---|---|
* | $5.0m | Seed | |
Total Funding | 000k |
USD | 2023 |
---|---|
Revenues | 0000 |
EBITDA | 0000 |
Profit | 0000 |
EV | 0000 |
EV / revenue | 00.0x |
EV / EBITDA | 00.0x |
R&D budget | 0000 |
Source: Dealroom estimates
Related Content
Via Scientific, accessible at viascientific.com, is a cutting-edge startup that specializes in simplifying and enhancing multi-omics data processing and analytics. Multi-omics refers to the comprehensive analysis of various biological data types, such as genomics, proteomics, and metabolomics, which are crucial for advanced scientific research. Via Scientific's flagship product, Foundry, is a fully integrated platform designed to streamline these complex processes, enabling researchers to focus on their scientific inquiries without the need for extensive coding skills.
The company primarily serves scientists, computational biologists, and bioinformaticians working in research labs, academic institutions, and biotech companies. These clients often deal with large-scale biological data and require robust tools to manage, analyze, and interpret this information efficiently. Foundry offers a suite of features, including customizable pipelines, metadata tracking, and analytics, all within an easy-to-use interface. This platform ensures that users can track every change, duplicate results, and collaborate seamlessly, adhering to FAIR (Findable, Accessible, Interoperable, and Reusable) standards.
Via Scientific operates in the biotech and life sciences market, which is rapidly growing due to advancements in personalized medicine and genomics. The company's business model revolves around providing subscription-based access to its Foundry platform. Clients pay for the software as a service (SaaS), which includes continuous updates, support, and access to integrated tools like RStudio and Jupyter Notebook. This model ensures a steady revenue stream while fostering long-term relationships with clients.
In summary, Via Scientific makes money by offering a subscription-based platform that simplifies multi-omics data processing and analytics, helping researchers save time and focus on generating scientific insights. The company's innovative approach and user-friendly tools position it well in the competitive biotech market.
Keywords: multi-omics, data processing, analytics, biotech, life sciences, SaaS, FAIR standards, research labs, bioinformatics, genomics.